Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-14

Clinical Trial Update: Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function [NA]

View source ↗

Summary

A cross-over trial evaluating whether acipimox-induced lipid lowering affects cardiac and skeletal muscle mitochondrial function in individuals with type 2 diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acipimox (Acipimox)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Diabetes Mellitus, Type 2, Cardiomyopathy, Dilated | NA | Status: COMPLETED